← Back to Search

Coping Strategies for Suicidal Thoughts

N/A

Recruiting

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within two hours of each micro-randomization

Awards & highlights

Study Summary

This trial will study if a smartphone intervention can help adults with suicidal thoughts use safety plans & coping strategies and reduce thoughts.

Who is the study for?

This trial is for adults hospitalized with suicidal thoughts who can speak and write English fluently, own a smartphone, and are able to participate fully in the study. Those with cognitive impairments, intellectual disabilities, violent behavior or psychotic symptoms that affect understanding of the study cannot join.Check my eligibility

What is being tested?

The study tests a real-time smartphone-based intervention promoting safety plans and coping strategies to manage suicidal thoughts. It checks if automated reminders increase strategy use and reduce suicidal ideation among participants answering surveys several times daily post-hospitalization.See study design

What are the potential side effects?

Since this trial involves non-medical interventions like coping strategies delivered via smartphones, traditional physical side effects are not expected. However, there may be emotional or psychological responses to the content or process of the intervention.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within two hours of each micro-randomization

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within two hours of each micro-randomization

This trial's timeline: 3 weeks for screening, Varies for treatment, and within two hours of each micro-randomization for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Extent to which the real-time intervention may be successfully used or implemented as assessed by the Feasibility of Intervention Measure

Intervention engagement as assessed by the number of real-time interventions received and percentage of real-time interventions completed

Participant approval of the real-time intervention as assessed by the Acceptability of Intervention Measure

Secondary outcome measures

Self-reported momentary suicidal urges and intent

Self-reported safety plan and coping strategy use

Trial Design

1Treatment groups

Experimental Treatment

Group I: Real-time intervention for promoting safety plan and coping strategy useExperimental Treatment9 Interventions

Momentary surveys in which elevated (non-zero but < 8 out of 10) levels of suicidal intent or high (>= 8 out of 10) suicidal urges are reported will be randomized either to receive a real-time intervention that consists of automated, interactive reminders with suggested strategies for coping with suicidal thoughts or no intervention. If randomized to receive an intervention, the intervention type will also be randomized (at equal probabilities) to suggest either coping strategies from the participant's personalized safety plan or general common coping strategies.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor

2,935 Previous Clinical Trials

13,198,616 Total Patients Enrolled

17 Trials studying Suicide

5,128 Patients Enrolled for Suicide

Media Library

Promoting Safety Plan and Coping Strategy Use Clinical Trial Eligibility Overview. Trial Name: NCT05791643 — N/A

Suicide Research Study Groups: Real-time intervention for promoting safety plan and coping strategy use

Suicide Clinical Trial 2023: Promoting Safety Plan and Coping Strategy Use Highlights & Side Effects. Trial Name: NCT05791643 — N/A

Promoting Safety Plan and Coping Strategy Use 2023 Treatment Timeline for Medical Study. Trial Name: NCT05791643 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open vacancies to participate in this medical trial?

"This clinical trial, initially announced on July 5th 2023 and updated lastly on the 6th of that same month, is currently open to patient enrolment according to information available through clinicaltrials.gov."

Answered by AI

How many individuals have opted to participate in this medical inquiry?

"Affirmative. According to the clinicaltrials.gov repository, this trial is actively recruiting participants since its original posting on July 5th 2023 and subsequent update a day later. 25 patients need to be enrolled at two distinct medical sites in order for the study to proceed as planned."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Promoting Safety Plan and Coping Strategy Use Among Adults With Suicidal Thoughts

Kate Bentley, PhD 2023. "Promoting Safety Plan and Coping Strategy Use Among Adults With Suicidal Thoughts". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05791643.